Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.

Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S, Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S, Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G, Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R, Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F, D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G, Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group.

J Autoimmun. 2020 Jan 8:102397. doi: 10.1016/j.jaut.2019.102397. [Epub ahead of print]

PMID:
31926833
2.

From structure to function for the characterization of ERAP1 active site in Behçet syndrome. A novel polymorphism associated with known gene variations.

Padula MC, Leccese P, Lascaro N, Carbone T, Limongi AR, Radice RP, Padula AA, D'Angelo S, Martelli G.

Mol Immunol. 2020 Jan;117:155-159. doi: 10.1016/j.molimm.2019.11.005. Epub 2019 Nov 29.

PMID:
31790864
3.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
4.

Identification of a de novo NLRP3 gene variation in an Italian Behçet syndrome patient.

Padula MC, Leccese P, Lascaro N, Padula AA, Carbone T, Martelli G, D'Angelo S.

Int J Immunogenet. 2019 Oct;46(5):339-341. doi: 10.1111/iji.12442. Epub 2019 Jun 10.

PMID:
31183983
5.

Behçet's Disease: An Overview of Etiopathogenesis.

Leccese P, Alpsoy E.

Front Immunol. 2019 May 10;10:1067. doi: 10.3389/fimmu.2019.01067. eCollection 2019. Review.

6.

HLA-B*51 subtypes molecular analysis in a series of Italian patients with Behçet's syndrome.

Leccese P, Padula MC, Santospirito EV, Colucci R, Lascaro N, D'Angelo S.

Joint Bone Spine. 2019 Nov;86(6):807-808. doi: 10.1016/j.jbspin.2019.04.011. Epub 2019 May 5. No abstract available.

PMID:
31067502
7.

Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet's syndrome patients: a preliminary case-control study.

Padula MC, Leccese P, Pellizzieri E, Padula AA, Gilio M, Carbone T, Lascaro N, Tramontano G, Martelli G, D'Angelo S.

Intern Emerg Med. 2019 Aug;14(5):713-718. doi: 10.1007/s11739-019-02056-w. Epub 2019 Feb 28.

PMID:
30820838
8.

Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach.

Padula MC, Leccese P, Lascaro N, Carbone T, Gilio M, Padula AA, Martelli G, D'Angelo S.

Hum Immunol. 2019 May;80(5):335-338. doi: 10.1016/j.humimm.2019.02.003. Epub 2019 Feb 8.

PMID:
30742879
9.

Brain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT study.

D'Angelo S, Chiaravalloti A, Ursini F, Barbagallo G, Gilio M, Leccese P, De Giorgio R, Di Giorgio E, Schillaci O.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):148-149. Epub 2018 Dec 14. No abstract available.

10.

Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis.

Felice C, Leccese P, Scudeller L, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Olivieri I, Armuzzi A; Italian SpA-IBD Expert Panel Group.

Clin Exp Immunol. 2019 Apr;196(1):123-138. doi: 10.1111/cei.13246. Epub 2019 Jan 9.

PMID:
30554407
11.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
12.

New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.

Santarsiero A, Leccese P, Convertini P, Padula A, Abriola P, D'Angelo S, Bisaccia F, Infantino V.

Mediators Inflamm. 2018 Jun 28;2018:1419352. doi: 10.1155/2018/1419352. eCollection 2018.

13.

Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement.

Olivieri I, Accorinti M, Abicca I, Bisceglia P, Cimino L, Latanza L, Leccese P, Lubrano E, Marchesoni A, Miserocchi E, Neri P, Salvarani C, Scarpa R, D'Angelo S; CORE Study Group.

Rheumatol Int. 2018 Sep;38(9):1727-1734. doi: 10.1007/s00296-018-4094-1. Epub 2018 Jun 30.

PMID:
29961101
14.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2019 Feb;48(4):752-762. doi: 10.1016/j.semarthrit.2018.05.008. Epub 2018 May 19.

PMID:
29954598
15.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
16.

ERAP1 molecular characterization: Identification of a de novo allelic variant.

Padula MC, Leccese P, Padula AA, D'Angelo S, Martelli G.

HLA. 2018 Mar 26. doi: 10.1111/tan.13262. [Epub ahead of print]

PMID:
29577660
17.

Safety of treatment options for spondyloarthritis: a narrative review.

D'Angelo S, Carriero A, Gilio M, Ursini F, Leccese P, Palazzi C.

Expert Opin Drug Saf. 2018 May;17(5):475-486. doi: 10.1080/14740338.2018.1448785. Epub 2018 Mar 14. Review.

PMID:
29505325
18.

Pure red aplasia induced by sodium valproate in a patient with Behçet's syndrome.

Leccese P, Attolico I, Padula A, Diplomatico A, D'Angelo S, Olivieri I.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):132. Epub 2017 Oct 27. No abstract available.

PMID:
29148419
19.

A suggested algorithm for detection of multi drug-resistant tuberculosis in Zimbabwe.

Makamure B, Makumbirofa S, Bandason T, Leccese P, Mutetwa R, Robertson V, Mason P.

J Infect Dev Ctries. 2017 Sep 5;11(8):611-618. doi: 10.3855/jidc.8009.

PMID:
31085822
20.

Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort.

Ursini F, D'Angelo S, Padula A, Leccese P, Abignano G, Mennillo GA, Ammerata G, De Sarro G, Olivieri I.

Clin Rheumatol. 2017 Dec;36(12):2871-2872. doi: 10.1007/s10067-017-3709-3. Epub 2017 Jun 3. No abstract available.

PMID:
28578491
21.

Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders.

D'Angelo S, Tramontano G, Gilio M, Leccese P, Olivieri I.

Open Access Rheumatol. 2017 Mar 2;9:21-28. doi: 10.2147/OARRR.S56073. eCollection 2017. Review.

22.

Golimumab for the treatment of axial spondyloarthritis.

Palazzi C, D'angelo S, Gilio M, Leccese P, Padula A, Olivieri I.

Expert Opin Biol Ther. 2017 Jan;17(1):129-133. Epub 2016 Nov 9. Review.

PMID:
27817204
23.

Highlights of the 17th International Conference on Behçet's syndrome.

Esatoglu SN, Hatemi G, Leccese P, Olivieri I.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):3-9. Epub 2016 Oct 25. No abstract available.

24.

Improvements in diagnostic tools for early detection of psoriatic arthritis.

D'Angelo S, Palazzi C, Gilio M, Leccese P, Padula A, Olivieri I.

Expert Rev Clin Immunol. 2016 Nov;12(11):1209-1215. Epub 2016 Jun 10. Review.

PMID:
27284965
25.

Behcet's syndrome in nonendemic regions.

Leccese P, Yazici Y, Olivieri I.

Curr Opin Rheumatol. 2017 Jan;29(1):12-16. Review.

PMID:
27684358
26.

Intrinsic Connections of the Core Auditory Cortical Regions and Rostral Supratemporal Plane in the Macaque Monkey.

Scott BH, Leccese PA, Saleem KS, Kikuchi Y, Mullarkey MP, Fukushima M, Mishkin M, Saunders RC.

Cereb Cortex. 2017 Jan 1;27(1):809-840. doi: 10.1093/cercor/bhv277.

27.

Pharmacological therapy of spondyloarthritis.

Palazzi C, D'Angelo S, Gilio M, Leccese P, Padula A, Olivieri I.

Expert Opin Pharmacother. 2015;16(10):1495-504. doi: 10.1517/14656566.2015.1052744. Epub 2015 Jun 14. Review.

PMID:
26073668
28.

What do patients want? Survey of patient desires for education in an urban university hospital.

Seibert T, Veazey K, Leccese P, Druck J.

West J Emerg Med. 2014 Nov;15(7):764-9. doi: 10.5811/westjem.2014.9.20674. Epub 2014 Oct 29.

29.

An update on the management of hepatitis C virus-related arthritis.

Palazzi C, D'Amico E, D'Angelo S, Gilio M, Leccese P, Olivieri I.

Expert Opin Pharmacother. 2014 Oct;15(14):2039-45. doi: 10.1517/14656566.2014.946404. Epub 2014 Aug 22. Review.

PMID:
25146875
30.

Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.

Interlandi E, Leccese P, Olivieri I, Latanza L.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S58-62. Epub 2014 Jul 8.

PMID:
25005224
31.

Safety of anti-tumor necrosis factor agents in psoriatic arthritis - an update.

Palazzi C, D'Angelo S, Leccese P, Padula A, Olivieri I.

Expert Opin Drug Saf. 2014 Feb;13(2):191-6. doi: 10.1517/14740338.2014.857655. Epub 2013 Nov 13. Review.

PMID:
24219428
32.

Spondyloarthritis with onset after age 45.

Olivieri I, D'Angelo S, Padula A, Leccese P, Palazzi C.

Curr Rheumatol Rep. 2013 Dec;15(12):374. doi: 10.1007/s11926-013-0374-7. Review.

PMID:
24170254
33.

High prevalence of Behçet's disease in southern Italy.

Olivieri I, Leccese P, Padula A, Nigro A, Palazzi C, Gilio M, D'Angelo S.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):28-31. Epub 2013 Apr 2.

PMID:
23557837
34.

Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis.

Olivieri I, D'Angelo S, Palazzi C, Leccese P, Nigro A, Padula A.

Reumatismo. 2013 Mar 28;65(1):1-3. doi: 10.4081/reumatismo.2013.1. No abstract available.

PMID:
23550255
35.

Ochronotic arthropathy of the spine limited to the thoracic section.

Palazzi C, D'Angelo S, Leccese P, Nigro A, Olivieri I.

Rheumatology (Oxford). 2013 May;52(5):799. doi: 10.1093/rheumatology/kes396. Epub 2013 Jan 7. No abstract available.

PMID:
23300332
36.

Can we reduce the dosage of biologics in spondyloarthritis?

Olivieri I, D'Angelo S, Padula A, Leccese P, Nigro A, Palazzi C.

Autoimmun Rev. 2013 May;12(7):691-3. doi: 10.1016/j.autrev.2012.08.013. Epub 2012 Aug 23. Review.

PMID:
22940233
37.

Late-onset spondyloarthritis: subset that should not be forgotten.

Olivieri I, D'Angelo S, Palazzi C, Leccese P, Padula A.

J Rheumatol. 2012 Jun;39(6):1110-2. doi: 10.3899/jrheum.120184. Epub 2012 May 15. No abstract available.

PMID:
22589252
38.

Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritis.

Olivieri I, Cutro MS, D'Angelo S, Leccese P, Mennillo GA, Scarano E, Abate R, Palazzi C, Padula A.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):290-6. Epub 2012 Apr 13.

PMID:
22325303
39.

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.

Olivieri I, Leccese P, D'Angelo S, Padula A, Nigro A, Palazzi C, Coniglio G, Latanza L.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S54-7. Epub 2011 Sep 27.

PMID:
21968237
40.

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.

Leccese P, Latanza L, D'Angelo S, Padula A, Olivieri I.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S93. Epub 2011 Sep 27. No abstract available.

PMID:
21813069
41.

Worsening of psoriasis with rituximab therapy.

Olivieri I, D'Angelo S, Leccese P, Vertone D, Olivieri A.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):926. Epub 2011 Jan 4. No abstract available.

PMID:
21205468
42.

Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.

Leccese P, D'Angelo S, Angela P, Coniglio G, Olivieri I.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S102. Epub 2010 Sep 24. No abstract available.

PMID:
20868587
43.

Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.

Atzeni F, Leccese P, D'Angelo S, Sarzi-Puttini P, Olivieri I.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S94. Epub 2010 Sep 24. No abstract available.

PMID:
20868581
44.

Emerging drugs for psoriatic arthritis.

Olivieri I, D'Angelo S, Palazzi C, Lubrano E, Leccese P.

Expert Opin Emerg Drugs. 2010 Sep;15(3):399-414. doi: 10.1517/14728214.2010.497139. Review.

PMID:
20528612
45.

Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.

Olivieri I, D' Angelo S, Padula A, Leccese P, Mennillo GA.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S112. No abstract available.

PMID:
19796550
46.

Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.

D'Angelo S, Cutro MS, Lubrano E, Leccese P, Mennillo GA, Ferrara N, Olivieri I.

Ann Rheum Dis. 2010 May;69(5):934-5. doi: 10.1136/ard.2009.119446. Epub 2009 Aug 9. No abstract available.

PMID:
19666936
47.

Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.

Olivieri I, Padula A, Leccese P, D'Angelo S, Giasi V.

J Rheumatol. 2009 Apr;36(4):855. doi: 10.3899/jrheum.081063. No abstract available.

PMID:
19342728
48.

Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.

D'Angelo S, Mennillo GA, Cutro MS, Leccese P, Nigro A, Padula A, Olivieri I.

J Rheumatol. 2009 Feb;36(2):368-70. doi: 10.3899/jrheum.080596. Epub 2009 Feb 4.

PMID:
19208566

Supplemental Content

Loading ...
Support Center